News tagged with drug manufacturers
Related topics: centers for disease control and prevention , food and drug administration , health officials , drug
Renaissance in new drugs for rare diseases
Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, ...
Medications
May 13, 2013 |
not rated yet |
0
Potential diabetes breakthrough: Researchers discover new hormone spurring beta cell production
Researchers at the Harvard Stem Cell Institute (HSCI) have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes, a metabolic illness afflicting an estimated ...
Medical research
Apr 25, 2013 |
4.9 / 5 (12) |
0
|
Health industry payment details to be publicly available
(HealthDay)—As part of the National Physician Payment Transparency Program and in compliance with a provision in the Affordable Care Act (ACA), the government will make information about financial relationships ...
Health
May 02, 2013 |
5 / 5 (1) |
0
The perils of delivering anti-malarial drugs through private sector examined
(Medical Xpress)—Getting high-quality anti-malarial drugs to people in places like Zanzibar and Mozambique is a tricky business.
Medications
Nov 09, 2012 |
not rated yet |
0
|
Breast stem-cell research: Receptor teamwork is required and a new pathway may be involved
Breast-cancer researchers at the University of Wisconsin-Madison have found that two related receptors in a robust signaling pathway must work together as a team to maintain normal activity in mammary stem cells.
Cancer
May 30, 2012 |
not rated yet |
0
|
Neuroscientists' discovery could bring relief to epilepsy sufferers
Researchers at the University of California, Riverside have made a discovery in the lab that could help drug manufacturers develop new antiepileptic drugs and explore novel strategies for treating seizures associated with ...
Medical research
Jun 21, 2011 |
not rated yet |
1
|
FDA rejects two HIV drugs from Gilead Sciences
Gilead Sciences Inc. says that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the company's manufacturing facilities.
Medications
Apr 29, 2013 |
1 / 5 (1) |
0
Fearing abuse, US blocks generic OxyContin (Update)
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications
Apr 16, 2013 |
not rated yet |
1
Analysis finds vitamin D potency varies widely in dietary supplements
Vitamin D supplement potency varies widely, and the amount of vitamin D in over-the counter and compounded supplements does not necessarily match the amount listed on the label, according to a research letter published in ...
Health
Feb 11, 2013 |
5 / 5 (2) |
1
Mining information contained in clinical notes could yield early signs of harmful drug reactions
Mining the records of routine interactions between patients and their care providers can detect drug side effects a couple of years before an official alert from the U.S. Food and Drug Administration, a Stanford University ...
Medications
Apr 10, 2013 |
not rated yet |
0
|
Lung-on-a-Chip wins prize for potentially reducing need for animal testing
In a London ceremony today, Wyss Founding Director Don Ingber, M.D., Ph.D., received the NC3Rs 3Rs Prize from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research ...
Medical research
Feb 26, 2013 |
not rated yet |
0
Drug maker Novartis loses India patent battle (Update)
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world ...
Medications
Apr 01, 2013 |
5 / 5 (3) |
0
Misuse of drug patenting could cost the health system billions
(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.
Medications
Apr 10, 2013 |
5 / 5 (1) |
0
|
India's global pharmacy role threatened by EU pact
(AP) -- Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted ...
Medications
Feb 10, 2012 |
not rated yet |
0
FDA: Novartis recall may also affect painkillers
(AP) -- The Food and Drug Administration is warning patients about a potential mix-up between powerful prescription pain drugs and common over-the-counter medications like Excedrin and Gas-X made at a Novartis manufacturing ...
Medications
Jan 09, 2012 |
3 / 5 (1) |
1
